LSK Technologies Analysis: $125K Raised
What is LSK Technologies?
LSK Technologies provides a platform for nucleic acid testing, delivering rapid and accurate results from various samples without traditional laboratory requirements.
Employees
2
Founded
2020
Revenue
$140k-$5M
Product Features & Capabilities
- High-throughput plate reader for viral and antibody detection, molecular kit for multimode testing, scalable plug-and-play testing solution for PCR-equivalent tests, fast results in 30 minutes, advanced camera vision technology for quantitative analysis.
How much LSK Technologies raised
Seed - $125,000
August 25, 2020Lead Investor: Y Combinator
Who are the founders of LSK Technologies
SC
Seray Cicek
Founder
LG
Livia Guo
Founder
Investors
- Canadian Institutes of Health Research
- Front Row Ventures
- Government of Canada
- Velocity
- Y-Combinator
Market Focus
LSK Technologies primarily focuses on the biotechnology industry, specifically in the area of nucleic acid testing and diagnostics.
Competitors Overview
LSK Technologies operates in the nucleic acid testing market, where it faces competition from several notable companies. Key competitors include:
- Roche: A leader in diagnostics, Roche offers a wide range of nucleic acid testing solutions, including PCR and other amplification technologies. T
See something that needs updating? Suggest edits to this profile.